BACKGROUND: Cryopreserved ovarian tissue can be retransplanted to restore fertility after radiation or chemotherapy. To date, 15 live births after retransplantation have been reported worldwide. We report the first pregnancy and the first live birth after retransplantation in Germany. CASE REPORT: A 25-year-old female patient received initial chemotherapy and radiation of the mediastinum for Hodgkin's lymphoma in 2003 and suffered a relapse two years later. Ovarian tissue was laparoscopically removed and cryopreserved, and she was then treated with high-dose chemotherapy and stem cell transplantation. She remained in remission for 5 years and she could not conceive during this time. The cryopreserved ovarian tissue was thawed and laparoscopically retransplanted into a peritoneal pouch in the ovarian fossa of the right pelvic wall. Three months later, her menopausal symptoms resolved, and she had her first spontaneous menstruation. Six months after retransplantation, after two normal menstrual cycles, low-dose follicle stimulating hormone (FSH) treatment induced the appearance of a dominant follicle in the tissue graft. Ovulation was then induced with human chorionic gonadotropin (HCG), whereupon the patient conceived naturally. After an uncomplicated pregnancy, she bore a healthy child by Caesarean section on 10 October 2011. Histological examination of biopsy specimens revealed that the ovarian tissue of the graft contained follicles in various stages of development, while the original ovaries contained only structures without any reproductive potential. CONCLUSION: This was the first live birth after retransplantation of cryopreserved ovarian tissue in Germany and also the first case with histological confirmation that the oocyte from which the patient conceived could only have come from the retransplanted tissue. In general, young women who will be undergoing chemotherapy and/or radiotherapy for cancer must be informed and counseled about the available options for fertility preservation.
BACKGROUND: Cryopreserved ovarian tissue can be retransplanted to restore fertility after radiation or chemotherapy. To date, 15 live births after retransplantation have been reported worldwide. We report the first pregnancy and the first live birth after retransplantation in Germany. CASE REPORT: A 25-year-old female patient received initial chemotherapy and radiation of the mediastinum for Hodgkin's lymphoma in 2003 and suffered a relapse two years later. Ovarian tissue was laparoscopically removed and cryopreserved, and she was then treated with high-dose chemotherapy and stem cell transplantation. She remained in remission for 5 years and she could not conceive during this time. The cryopreserved ovarian tissue was thawed and laparoscopically retransplanted into a peritoneal pouch in the ovarian fossa of the right pelvic wall. Three months later, her menopausal symptoms resolved, and she had her first spontaneous menstruation. Six months after retransplantation, after two normal menstrual cycles, low-dose follicle stimulating hormone (FSH) treatment induced the appearance of a dominant follicle in the tissue graft. Ovulation was then induced with human chorionic gonadotropin (HCG), whereupon the patient conceived naturally. After an uncomplicated pregnancy, she bore a healthy child by Caesarean section on 10 October 2011. Histological examination of biopsy specimens revealed that the ovarian tissue of the graft contained follicles in various stages of development, while the original ovaries contained only structures without any reproductive potential. CONCLUSION: This was the first live birth after retransplantation of cryopreserved ovarian tissue in Germany and also the first case with histological confirmation that the oocyte from which the patient conceived could only have come from the retransplanted tissue. In general, young women who will be undergoing chemotherapy and/or radiotherapy for cancer must be informed and counseled about the available options for fertility preservation.
Authors: Sherman J Silber; Kathleen M Lenahan; David J Levine; Jorge A Pineda; Kim S Gorman; Michael J Friez; Eric C Crawford; Roger G Gosden Journal: N Engl J Med Date: 2005-06-07 Impact factor: 91.245
Authors: T Maltaris; A Dimmler; A Müller; H Binder; I Hoffmann; J Kohl; E Siebzehnrübl; M W Beckmann; R Dittrich Journal: Reprod Domest Anim Date: 2005-06 Impact factor: 2.005
Authors: J Donnez; M M Dolmans; D Demylle; P Jadoul; C Pirard; J Squifflet; B Martinez-Madrid; A van Langendonckt Journal: Lancet Date: 2004 Oct 16-22 Impact factor: 79.321
Authors: Ralf Dittrich; Andreas Mueller; Helge Binder; Patricia G Oppelt; Stefan P Renner; Tamme Goecke; Inge Hoffmann; W Matthias Beckmann Journal: Dtsch Arztebl Int Date: 2008-04-11 Impact factor: 5.594
Authors: Michael von Wolff; Markus Montag; Ralf Dittrich; Dominik Denschlag; Frank Nawroth; Barbara Lawrenz Journal: Arch Gynecol Obstet Date: 2011-03-24 Impact factor: 2.344
Authors: T Seshadri; D Gook; S Lade; A Spencer; A Grigg; K Tiedemann; J McKendrick; P Mitchell; C Stern; J F Seymour Journal: Br J Cancer Date: 2006-04-10 Impact factor: 7.640
Authors: V Isachenko; R Dittrich; G Keck; E Isachenko; G Rahimi; H van der Ven; M Montag; I Hoffmann; A Müller; W Distler; M W Beckmann; P Mallmann Journal: Geburtshilfe Frauenheilkd Date: 2012-10 Impact factor: 2.915
Authors: David M Lee; Carrie M Thomas; Fuhua Xu; Richard R Yeoman; Jing Xu; Richard L Stouffer; Don P Wolf; Mary B Zelinski Journal: J Assist Reprod Genet Date: 2017-09-23 Impact factor: 3.412
Authors: S E Gellert; S E Pors; S G Kristensen; A M Bay-Bjørn; E Ernst; C Yding Andersen Journal: J Assist Reprod Genet Date: 2018-03-01 Impact factor: 3.412
Authors: K Kyono; T Hashimoto; M Toya; M Koizumi; C Sasaki; S Shibasaki; N Aono; Y Nakamura; R Obata; N Okuyama; Y Ogura; H Igarashi Journal: J Assist Reprod Genet Date: 2017-09-02 Impact factor: 3.412
Authors: Francesca E Duncan; Mary Zelinski; Alexander H Gunn; Jennifer E Pahnke; Conor L O'Neill; Nucharin Songsasen; Ryan I Woodruff; Teresa K Woodruff Journal: Reproduction Date: 2016-08-04 Impact factor: 3.906